{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:19:36Z","timestamp":1779020376730,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Expression of mutant huntingtin (htt) protein has been shown to cause metabolic imbalance in animal models of Huntington disease (HD). The pathways involved are not fully understood but dysfunction of both the hypothalamus and brown adipose tissue (BAT) has been implicated. Here we show that targeted expression of mutant HTT in the hypothalamus leads to loss of the A13 dopaminergic cell group located in the zona incerta and reduced mRNA expression of neuropeptide Y1 receptor in the hypothalamus. Furthermore, this is accompanied by downregulation of uncoupling protein 1 expression and PPAR\u03b3 coactivator-1 alpha in BAT and a rapid body weight gain. Taken together, our data might provide a mechanistic link between expression of mutant HTT, reduced activity of a hypothalamic dopaminergic pathway and dysfunction of BAT and in part explain the development of an obese phenotype in HD mouse models.<\/jats:p>","DOI":"10.1038\/srep14598","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T09:16:52Z","timestamp":1443604612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue"],"prefix":"10.1038","volume":"5","author":[{"given":"Rana","family":"Soylu-Kucharz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Adlesic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Kirik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"Peters\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"BFsrep14598_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.coph.2013.09.010","volume":"13","author":"AP Coll","year":"2013","unstructured":"Coll, A. P. & Yeo, G. S. The hypothalamus and metabolism: integrating signals to control energy and glucose homeostasis. Curr Opin Pharmacol 13, 970\u2013976, 10.1016\/j.coph.2013.09.010 (2013).","journal-title":"Curr Opin Pharmacol"},{"key":"BFsrep14598_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.yfrne.2009.08.002","volume":"31","author":"C Sanchez-Lasheras","year":"2010","unstructured":"Sanchez-Lasheras, C., Konner, A. C. & Bruning, J. C. Integrative neurobiology of energy homeostasis-neurocircuits, signals and mediators. Front Neuroendocrinol 31, 4\u201315, 10.1016\/j.yfrne.2009.08.002 (2010).","journal-title":"Front Neuroendocrinol"},{"key":"BFsrep14598_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrn3745","volume":"15","author":"GJ Morton","year":"2014","unstructured":"Morton, G. J., Meek, T. H. & Schwartz, M. W. Neurobiology of food intake in health and disease. Nat Rev Neurosci 15, 367\u2013378, 10.1038\/nrn3745 (2014).","journal-title":"Nat Rev Neurosci"},{"key":"BFsrep14598_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.tins.2007.06.004","volume":"30","author":"RD Palmiter","year":"2007","unstructured":"Palmiter, R. D. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 30, 375\u2013381, 10.1016\/j.tins.2007.06.004 (2007).","journal-title":"Trends Neurosci"},{"key":"BFsrep14598_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tics.2010.11.001","volume":"15","author":"ND Volkow","year":"2011","unstructured":"Volkow, N. D., Wang, G. J. & Baler, R. D. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 15, 37\u201346, 10.1016\/j.tics.2010.11.001 (2011).","journal-title":"Trends Cogn Sci"},{"key":"BFsrep14598_CR6","unstructured":"Dahlstroem, A. & Fuxe, K. Evidence for the Existence of Monoamine-Containing Neurons in the Central Nervous System. I. Demonstration of Monoamines in the Cell Bodies of Brain Stem Neurons. Acta Physiol Scand Suppl, SUPPL 232: 231\u2013255 (1964)."},{"key":"BFsrep14598_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0165-3806(82)90039-6","volume":"256","author":"H Baker","year":"1982","unstructured":"Baker, H., Joh, T. H. & Reis, D. J. Time of appearance during development of differences in nigrostriatal tyrosine hydroxylase activity in two inbred mouse strains. Brain Res 256, 157\u2013165 (1982).","journal-title":"Brain Res"},{"key":"BFsrep14598_CR8","first-page":"433","volume":"Vol. 20","author":"KJ Lookingland","year":"2005","unstructured":"Lookingland, K. J. & Moore, K. E. Functional neuroanatomy of hypothalamic dopaminergic neuroendocrine systems. Handbook of Chemical Neuroanatomy Vol. 20, Chapter 8: 433\u2013521 (2005).","journal-title":"Handbook of Chemical Neuroanatomy"},{"key":"BFsrep14598_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000054522","volume":"71","author":"KG Bina","year":"2000","unstructured":"Bina, K. G. & Cincotta, A. H. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain and hyperglycemia in ob\/ob mice. Neuroendocrinology 71, 68\u201378, 54522 (2000).","journal-title":"Neuroendocrinology"},{"key":"BFsrep14598_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejphar.2003.08.100","volume":"480","author":"H Pijl","year":"2003","unstructured":"Pijl, H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a \u201cthrifty\u201d genotype underlying the metabolic syndrome? Eur J Pharmacol 480, 125\u2013131 (2003).","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"BFsrep14598_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"M MACDONALD","year":"1993","unstructured":"HDCRG. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"BFsrep14598_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-010-0742-6","volume":"120","author":"S Gabery","year":"2010","unstructured":"Gabery, S. et al. Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses. Acta Neuropathol 120, 777\u2013788, 10.1007\/s00401-010-0742-6 (2010).","journal-title":"Acta Neuropathol"},{"key":"BFsrep14598_CR13","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/brain\/awn244","volume":"131","author":"M Politis","year":"2008","unstructured":"Politis, M. et al. Hypothalamic involvement in Huntington\u2019s disease: an in vivo PET study. Brain 131, 2860\u20132869, 10.1093\/brain\/awn244 (2008).","journal-title":"Brain"},{"key":"BFsrep14598_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI45691","volume":"121","author":"F Mochel","year":"2011","unstructured":"Mochel, F. & Haller, R. G. Energy deficit in Huntington disease: why it matters. J Clin Invest 121, 493\u2013499, 10.1172\/JCI45691 (2011).","journal-title":"J Clin Invest"},{"key":"BFsrep14598_CR15","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","volume":"15","author":"M Bjorkqvist","year":"2006","unstructured":"Bjorkqvist, M. et al. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington\u2019s disease. Hum Mol Genet 15, 1713\u20131721, 10.1093\/hmg\/ddl094 (2006).","journal-title":"Hum Mol Genet"},{"key":"BFsrep14598_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","volume":"13","author":"S Hult","year":"2011","unstructured":"Hult, S. et al. Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits. Cell Metab 13, 428\u2013439, 10.1016\/j.cmet.2011.02.013 (2011).","journal-title":"Cell Metab"},{"key":"BFsrep14598_CR17","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1523\/JNEUROSCI.23-17-06956.2003","volume":"23","author":"SH Li","year":"2003","unstructured":"Li, S. H. et al. Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington\u2019s disease. J Neurosci 23, 6956\u20136964 (2003).","journal-title":"J Neurosci"},{"key":"BFsrep14598_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506 (1996).","journal-title":"Cell"},{"key":"BFsrep14598_CR19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","volume":"18","author":"J Phan","year":"2009","unstructured":"Phan, J., Hickey, M. A., Zhang, P., Chesselet, M. F. & Reue, K. Adipose tissue dysfunction tracks disease progression in two Huntington\u2019s disease mouse models. Hum Mol Genet 18, 1006\u20131016, 10.1093\/hmg\/ddn428 (2009).","journal-title":"Hum Mol Genet"},{"key":"BFsrep14598_CR20","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","volume":"15","author":"JM Van Raamsdonk","year":"2006","unstructured":"Van Raamsdonk, J. M. et al. Body weight is modulated by levels of full-length huntingtin. Hum Mol Genet 15, 1513\u20131523, 10.1093\/hmg\/ddl072 (2006).","journal-title":"Hum Mol Genet"},{"key":"BFsrep14598_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt, P. et al. Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration. Cell Metab 4, 349\u2013362, 10.1016\/j.cmet.2006.10.004 (2006).","journal-title":"Cell Metab"},{"key":"BFsrep14598_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/er.2002-0012","volume":"24","author":"P Puigserver","year":"2003","unstructured":"Puigserver, P. & Spiegelman, B. M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24, 78\u201390, 10.1210\/er.2002-0012 (2003).","journal-title":"Endocr Rev"},{"key":"BFsrep14598_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2013.01.006","volume":"17","author":"YC Shi","year":"2013","unstructured":"Shi, Y. C. et al. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab 17, 236\u2013248, 10.1016\/j.cmet.2013.01.006 (2013).","journal-title":"Cell Metab"},{"key":"BFsrep14598_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fphys.2015.00004","volume":"6","author":"AL Poher","year":"2015","unstructured":"Poher, A. L., Altirriba, J., Veyrat-Durebex, C. & Rohner-Jeanrenaud, F. Brown adipose tissue activity as a target for the treatment of obesity\/insulin resistance. Front Physiol 6, 4, 10.3389\/fphys.2015.00004 (2015).","journal-title":"Front Physiol"},{"key":"BFsrep14598_CR25","doi-asserted-by":"publisher","first-page":"e105556","DOI":"10.1371\/journal.pone.0105556","volume":"9","author":"KS Lindenberg","year":"2014","unstructured":"Lindenberg, K. S. et al. Two-point magnitude MRI for rapid mapping of brown adipose tissue and its application to the R6\/2 mouse model of Huntington disease. PLoS One 9, e105556, 10.1371\/journal.pone.0105556 (2014).","journal-title":"PLoS One"},{"key":"BFsrep14598_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbadis.2010.09.009","volume":"1812","author":"J Eschbach","year":"2011","unstructured":"Eschbach, J. et al. Mutations in cytoplasmic dynein lead to a Huntington\u2019s disease-like defect in energy metabolism of brown and white adipose tissues. Biochim Biophys Acta 1812, 59\u201369, 10.1016\/j.bbadis.2010.09.009 (2011).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep14598_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/hmg\/ddr541","volume":"21","author":"A Johri","year":"2012","unstructured":"Johri, A. et al. Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington\u2019s disease. Hum Mol Genet 21, 1124\u20131137, 10.1093\/hmg\/ddr541 (2012).","journal-title":"Hum Mol Genet"},{"key":"BFsrep14598_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1159\/000327910","volume":"8","author":"A Johri","year":"2011","unstructured":"Johri, A. et al. Truncated peroxisome proliferator-activated receptor-gamma coactivator 1alpha splice variant is severely altered in Huntington\u2019s disease. Neurodegener Dis 8, 496\u2013503, 10.1159\/000327910 (2011).","journal-title":"Neurodegener Dis"},{"key":"BFsrep14598_CR29","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","volume":"19","author":"MA Pouladi","year":"2010","unstructured":"Pouladi, M. A. et al. Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum Mol Genet 19, 1528\u20131538, 10.1093\/hmg\/ddq026 (2010).","journal-title":"Hum Mol Genet"},{"key":"BFsrep14598_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/hmg\/ddi004","volume":"14","author":"A Petersen","year":"2005","unstructured":"Petersen, A. et al. Orexin loss in Huntington\u2019s disease. Hum Mol Genet 14, 39\u201347, 10.1093\/hmg\/ddi004 (2005).","journal-title":"Hum Mol Genet"},{"key":"BFsrep14598_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0361-9230(93)90082-M","volume":"30","author":"C Yokoyama","year":"1993","unstructured":"Yokoyama, C., Okamura, H. & Ibata, Y. Resistance of hypothalamic dopaminergic neurons to neonatal 6-hydroxydopamine toxicity. Brain Res Bull 30, 551\u2013559 (1993).","journal-title":"Brain Res Bull"},{"key":"BFsrep14598_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0006-8993(90)91055-L","volume":"527","author":"NA Seniuk","year":"1990","unstructured":"Seniuk, N. A., Tatton, W. G. & Greenwood, C. E. Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Brain Res 527, 7\u201320 (1990).","journal-title":"Brain Res"},{"key":"BFsrep14598_CR33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1212\/WNL.34.5.672","volume":"34","author":"F Javoy-Agid","year":"1984","unstructured":"Javoy-Agid, F. et al. Biochemistry of the hypothalamus in Parkinson\u2019s disease. Neurology 34, 672\u2013675 (1984).","journal-title":"Neurology"},{"key":"BFsrep14598_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0006-8993(94)91761-2","volume":"639","author":"K Shannak","year":"1994","unstructured":"Shannak, K. et al. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson\u2019s disease and normal subjects. Brain Res 639, 33\u201341 (1994).","journal-title":"Brain Res"},{"key":"BFsrep14598_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.expneurol.2008.07.021","volume":"214","author":"M Politis","year":"2008","unstructured":"Politis, M., Piccini, P., Pavese, N., Koh, S. B. & Brooks, D. J. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson\u2019s disease: an in vivo 11C-raclopride PET study. Exp Neurol 214, 112\u2013116, 10.1016\/j.expneurol.2008.07.021 (2008).","journal-title":"Exp Neurol"},{"key":"BFsrep14598_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks, W. A., Owen, J. B. & Erickson, M. A. Insulin in the brain: there and back again. Pharmacol Ther 136, 82\u201393, 10.1016\/j.pharmthera.2012.07.006 (2012).","journal-title":"Pharmacol Ther"},{"key":"BFsrep14598_CR37","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","volume":"21","author":"E Colin","year":"2005","unstructured":"Colin, E. et al. Akt is altered in an animal model of Huntington\u2019s disease and in patients. Eur J Neurosci 21, 1478\u20131488, 10.1111\/j.1460-9568.2005.03985.x (2005).","journal-title":"Eur J Neurosci"},{"key":"BFsrep14598_CR38","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00018-010-0305-y","volume":"67","author":"S Reijonen","year":"2010","unstructured":"Reijonen, S. et al. Downregulation of NF-kappaB signaling by mutant huntingtin proteins induces oxidative stress and cell death. Cell Mol Life Sci 67, 1929\u20131941, 10.1007\/s00018-010-0305-y (2010).","journal-title":"Cell Mol Life Sci"},{"key":"BFsrep14598_CR39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/brain\/awt355","volume":"137","author":"U Trager","year":"2014","unstructured":"Trager, U. et al. HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NFkappaB pathway dysregulation. Brain 137, 819\u2013833, 10.1093\/brain\/awt355 (2014).","journal-title":"Brain"},{"key":"BFsrep14598_CR40","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990\u20131993 (1997).","journal-title":"Science"},{"key":"BFsrep14598_CR41","doi-asserted-by":"publisher","first-page":"15538","DOI":"10.1074\/jbc.M110.105841","volume":"285","author":"E Susaki","year":"2010","unstructured":"Susaki, E. et al. Increased E4 activity in mice leads to ubiquitin-containing aggregates and degeneration of hypothalamic neurons resulting in obesity. J Biol Chem 285, 15538\u201315547, 10.1074\/jbc.M110.105841 (2010).","journal-title":"J Biol Chem"},{"key":"BFsrep14598_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/ajcn\/50.1.145","volume":"50","author":"LM Morales","year":"1989","unstructured":"Morales, L. M. et al. Nutritional evaluation of Huntington disease patients. Am J Clin Nutr 50, 145\u2013150 (1989).","journal-title":"Am J Clin Nutr"},{"key":"BFsrep14598_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.nut.2004.12.012","volume":"21","author":"A Trejo","year":"2005","unstructured":"Trejo, A., Boll, M. C., Alonso, M. E., Ochoa, A. & Velasquez, L. Use of oral nutritional supplements in patients with Huntington\u2019s disease. Nutrition 21, 889\u2013894, 10.1016\/j.nut.2004.12.012 (2005).","journal-title":"Nutrition"},{"key":"BFsrep14598_CR44","doi-asserted-by":"publisher","first-page":"10497","DOI":"10.1073\/pnas.0600913103","volume":"103","author":"C Cavadas","year":"2006","unstructured":"Cavadas, C. et al. Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion. Proc Natl Acad Sci USA 103, 10497\u201310502, 10.1073\/pnas.0600913103 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep14598_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fphys.2015.00036","volume":"6","author":"RA Busiello","year":"2015","unstructured":"Busiello, R. A., Savarese, S. & Lombardi, A. Mitochondrial uncoupling proteins and energy metabolism. Front Physiol 6, 36, 10.3389\/fphys.2015.00036 (2015).","journal-title":"Front Physiol"},{"key":"BFsrep14598_CR46","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cmet.2011.08.010","volume":"14","author":"D Sellayah","year":"2011","unstructured":"Sellayah, D., Bharaj, P. & Sikder, D. Orexin is required for brown adipose tissue development, differentiation and function. Cell Metab 14, 478\u2013490, 10.1016\/j.cmet.2011.08.010 (2011).","journal-title":"Cell Metab"},{"key":"BFsrep14598_CR47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/en.2013-1629","volume":"155","author":"D Sellayah","year":"2014","unstructured":"Sellayah, D. & Sikder, D. Orexin restores aging-related brown adipose tissue dysfunction in male mice. Endocrinology 155, 485\u2013501, 10.1210\/en.2013-1629 (2014).","journal-title":"Endocrinology"},{"key":"BFsrep14598_CR48","doi-asserted-by":"publisher","first-page":"15944","DOI":"10.1523\/JNEUROSCI.3909-11.2011","volume":"31","author":"D Tupone","year":"2011","unstructured":"Tupone, D., Madden, C. J., Cano, G. & Morrison, S. F. An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. J Neurosci 31, 15944\u201315955, 10.1523\/JNEUROSCI.3909-11.2011 (2011).","journal-title":"J Neurosci"},{"key":"BFsrep14598_CR49","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","volume":"92","author":"P Puigserver","year":"1998","unstructured":"Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829\u2013839 (1998).","journal-title":"Cell"},{"key":"BFsrep14598_CR50","first-page":"760","volume":"18","author":"L Ferreras","year":"1994","unstructured":"Ferreras, L., Kelada, A. S., McCoy, M. & Proietto, J. Early decrease in GLUT4 protein levels in brown adipose tissue of New Zealand obese mice. Int J Obes Relat Metab Disord 18, 760\u2013765 (1994).","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFsrep14598_CR51","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/med.2610130604","volume":"13","author":"JR Arch","year":"1993","unstructured":"Arch, J. R. & Kaumann, A. J. Beta 3 and atypical beta-adrenoceptors. Med Res Rev 13, 663\u2013729 (1993).","journal-title":"Med Res Rev"},{"key":"BFsrep14598_CR52","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1056\/NEJM199508103330605","volume":"333","author":"K Clement","year":"1995","unstructured":"Clement, K. et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333, 352\u2013354, 10.1056\/NEJM199508103330605 (1995).","journal-title":"N Engl J Med"},{"key":"BFsrep14598_CR53","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","volume":"4","author":"Y Barak","year":"1999","unstructured":"Barak, Y. et al. PPAR gamma is required for placental, cardiac and adipose tissue development. Mol Cell 4, 585\u2013595 (1999).","journal-title":"Mol Cell"},{"key":"BFsrep14598_CR54","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","volume":"22","author":"LP de Almeida","year":"2002","unstructured":"de Almeida, L. P., Ross, C. A., Zala, D., Aebischer, P. & Deglon, N. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels and protein length. J Neurosci 22, 3473\u20133483, 20026337 (2002).","journal-title":"J Neurosci"},{"key":"BFsrep14598_CR55","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/mt.2009.142","volume":"17","author":"A Ulusoy","year":"2009","unstructured":"Ulusoy, A., Sahin, G., Bjorklund, T., Aebischer, P. & Kirik, D. Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons. Mol Ther 17, 1574\u20131584, 10.1038\/mt.2009.142 (2009).","journal-title":"Mol Ther"},{"key":"BFsrep14598_CR56","unstructured":"Franklin, K. P. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates. 3rd edn, (Academic Press, 2008)."},{"key":"BFsrep14598_CR57","doi-asserted-by":"publisher","first-page":"e83050","DOI":"10.1371\/journal.pone.0083050","volume":"8","author":"B Baldo","year":"2013","unstructured":"Baldo, B., Soylu, R. & Petersen, A. Maintenance of basal levels of autophagy in Huntington\u2019s disease mouse models displaying metabolic dysfunction. PLoS One 8, e83050, 10.1371\/journal.pone.0083050 (2013).","journal-title":"PLoS One"},{"key":"BFsrep14598_CR58","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ar.1092310411","volume":"231","author":"MJ West","year":"1991","unstructured":"West, M. J., Slomianka, L. & Gundersen, H. J. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231, 482\u2013497, 10.1002\/ar.1092310411 (1991).","journal-title":"Anat Rec"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep14598","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep14598.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep14598.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:59:39Z","timestamp":1672963179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep14598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,26]]}},"alternative-id":["BFsrep14598"],"URL":"https:\/\/doi.org\/10.1038\/srep14598","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]},"assertion":[{"value":"28 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14598"}}